Royal Bank of Canada reaffirmed their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their price target on shares of Hookipa Pharma from […]